Clinical Trials · NCT07011667
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 609
- Start date
- Jun 2025
- Locations
- 46 sites, United States
- Primary endpoint
- Relative change in body weight